NephroGenex, Inc. Bankruptcy Case

KlaymanToskesMay 7, 2024

Nephrogenex, Inc. Investment Losses: KT Law Investigates ...

ApreaFeb 15, 2024

Aprea Therapeutics | Leaders in DDR-Targeted Solutions

Cole SchotzJun 17, 2022

Daniel F. X. Geoghan | Cole Schotz

RightsforinvestorsJul 22, 2020

NEPHROGENEX, INC. ALERT: NEPHROGENEX, INC. BANKRUPTCY …

Womble Bond DickinsonJul 22, 2020

Todd A. Atkinson | Womble Bond Dickinson

PR NewswireJul 20, 2020

Windtree Appoints John Hamill as Chief Financial Officer

InvestorvillageApr 11, 2019

The Evercore ISI US Biotech IPO Monitor Edition 1

Law FirmJan 1, 2018

norton annual survey bankr law 2018

TradelogsoftwareDec 29, 2017

Corporate Actions History for 2017

CreditriskmonitorDec 22, 2017

FRISK_Score_Predictions_2016-2017_3_1_2018.pdf

bankrupt.comMay 22, 2017

/raid1/www/Hosts/bankrupt/TCR_Public/170522.mbx

CasselsalpeterMay 1, 2017

NephroGenex sold assets to Medpace Research - Cassel Salpeter

Bankrupt.comJan 9, 2017

170109.mbx - Bankrupt.com

Bankrupt.comSep 30, 2016

160930.mbx - Bankrupt.com

bankrupt.comMay 4, 2016

160504.mbx - Bankrupt.com

BioworldMay 3, 2016

Two of IPO's bull run class file Chapter 11: Bind, Nephrogenex + ...

Bankrupt.comMay 3, 2016

160503.mbx - Bankrupt.com

ColeschotzMay 2, 2016

New Delaware Chapter 11 Filing - NephroGenex, Inc.

MarketScreenerMay 2, 2016

NephroGenex, Inc. : Commences Voluntary Chapter 11 Proceeding ...

CasselsalpeterMay 2, 2016

NephroGenex, Inc. Commences Voluntary Chapter 11 Proceeding ...

NephroGenex, Inc.